FAQ/Help |
Calendar |
Search |
Today's Posts |
08-24-2015, 01:34 PM | #5 | |||
|
||||
Senior Member
|
You echo my opinion about the use of ibogaine and its potential effect upon the addiction treatment industry. I am saddened by this realization, though cannot discern any other explanation, reading the history of the substance. The "pharmaceutical representatives" in attendance at the meeting during which ibogaine was banned were very much against the continued use/study of this substance--geez no surprise there. and their opinions prevailed.
One of the first postings about ibogaine on this forum, I think: http://neurotalk.psychcentral.com/sh...ad.php?t=23977 Again, if this substance really increases GDNF, WHY has it not been studied in PD models at least? thanks, madelyn
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
Ibogaine/Ibocaine--on anyone's radar? | Parkinson's Disease | |||
GDNF, BBB and Ibogaine revisited | Parkinson's Disease | |||
A Home for Ibogaine in Barcelona | Parkinson's Disease | |||
ibogaine patent details | Parkinson's Disease | |||
Ibogaine, GDNF and Parkinson's disease | Parkinson's Disease |